Your browser doesn't support javascript.
loading
Donor selection for KIR alloreactivity is associated with superior survival in haploidentical transplant with PTCy.
Zou, Jun; Kongtim, Piyanuch; Srour, Samer A; Greenbaum, Uri; Schetelig, Johannes; Heidenreich, Falk; Baldauf, Henning; Moore, Brandt; Saengboon, Supawee; Carmazzi, Yudith; Rondon, Gabriela; Ma, Qing; Rezvani, Katayoun; Shpall, Elizabeth J; Champlin, Richard E; Ciurea, Stefan O; Cao, Kai.
Affiliation
  • Zou J; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Kongtim P; Division of Hematology/Oncology, Department of Medicine, Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange, CA, United States.
  • Srour SA; Center of Excellence in Applied Epidemiology, Faculty of Medicine, Thammasat University, Pathumthani, Thailand.
  • Greenbaum U; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Schetelig J; Department of Hematology, Soroka University Medical Center, and Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
  • Heidenreich F; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Baldauf H; DKMS gemeinnützige GmbH, Tübingen, Germany.
  • Moore B; Department of Internal Medicine I, University Hospital Carl Gustav Carus, TU Dresden, Dresden, Germany.
  • Saengboon S; DKMS gemeinnützige GmbH, Tübingen, Germany.
  • Carmazzi Y; DKMS gemeinnützige GmbH, Tübingen, Germany.
  • Rondon G; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ma Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Rezvani K; Department of Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Champlin RE; Department of Hematopoietic Biology and Malignancy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Ciurea SO; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
  • Cao K; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Front Immunol ; 13: 1033871, 2022.
Article in En | MEDLINE | ID: mdl-36311784
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation Conditioning / Donor Selection Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transplantation Conditioning / Donor Selection Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans / Middle aged Language: En Journal: Front Immunol Year: 2022 Document type: Article Affiliation country: Estados Unidos Country of publication: Suiza